Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: A systematic review of the literature

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages 2637-2645

  Di Dalmazi, Guido ^a   Berr, Christina M ^a   Fassnacht, Martin ^a   Beuschlein, Felix ^a   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL GLANDS; ADRENAL INSUFFICIENCY; ADRENALECTOMY; ASYMPTOMATIC DISEASES; CUSHING SYNDROME; HUMANS; POSTOPERATIVE COMPLICATIONS; PREVALENCE;

EID: 84905851685     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1401     Document Type: Review

References (44)

1. Di Dalmazi G, Vicennati V, Rinaldi E, et al. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol. 2012;166: 669-677.
2. Erbil Y, Ademolu E, Ozbey N, et al. Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg. 2006;30:1665-1671.
3. Orth DN. Cushing's syndrome. N Engl J Med. 1995;332:791-803.
4. Chiodini I, Guglielmi G, Battista C, et al. Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status. J Clin Endocrinol Metab. 2004;89:2237-2241.
5. Graversen D, Vestergaard P, Stochholm K, Gravholt CH, Jørgensen JO. Mortality in Cushing's syndrome: a systematic review and metaanalysis. Eur J Intern Med. 2012;23:278-282.
6. Di Dalmazi G, Vicennati V, Garelli S, et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014;2:396-405.
7. Skalkeas G, Gogas JG, Sechas MN, Kostakis A, Pavlatos F. Cushing's syndrome. Analysis of 18 cases.AmJ Surg. 1982;143:363-366.
8. Daitch JA, Goldfarb DA, Novick AC. Cleveland Clinic experience with adrenal Cushing's syndrome. J Urol. 1997;158:2051-2055.
9. Chiodini I. Clinical review: diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab. 2011;96:1223-1236.
10. IacoboneM, Mantero F, Basso SM, Lumachi F, Favia G. Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients. J Endocrinol Invest. 2005;28:327-332.
11. Emral R, Uysal AR, Asik M, et al. Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr J. 2003;50:399-408.
12. Perysinakis I, Marakaki C, Avlonitis S, et al. Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome. Surg Endosc. 2013;27:2145-2148.
13. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab. 1992;75:826-832.
14. Iacobone M, Citton M, Viel G, et al. Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. Surgery. 2012;152:991-997.
15. Eller-Vainicher C, Morelli V, Salcuni AS, et al. Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur J Endocrinol. 2010;162:91-99.
16. McLeodMK, ThompsonNW, GrossMD, BondesonAG, Bondeson L. Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management. Am Surg. 1990;56:398-403.
17. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf). 2001;54:797-804.
18. Alesina PF, Hommeltenberg S, Meier B, et al. Posterior retroperitoneoscopic adrenalectomy for clinical and subclinical Cushing's syndrome. World J Surg. 2010;34:1391-1397.
19. He HC, Dai J, Shen ZJ, et al. Retroperitoneal adrenal-sparing surgery for the treatment of Cushing's syndrome caused by adrenocortical adenoma: 8-year experience with 87 patients. World J Surg. 2012;36:1182-1188.
20. Mitchell IC, Auchus RJ, Juneja K, et al. "Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients. Surgery. 2007;142:900-905.
21. Giordano R, Marinazzo E, Berardelli R, et al. Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur J Endocrinol. 2010;162: 779-785.
22. Toniato A, Merante-Boschin I, Opocher G, Pelizzo MR, Schiavi F, Ballotta E. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg. 2009;249:388-391.
23. Morelli V, Reimondo G, Giordano R, et al. Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. J Clin Endocrinol Metab. 2014;99:827-834.
24. Terzolo M, Pia A, Alì A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab. 2002;87: 998-1003.
25. Bertagna C, Orth DN. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 1981;71:855-875.
26. Pikkarainen L, Sane T, Reunanen A. The survival and well-being of patients treated for Cushing's syndrome. J Intern Med. 1999;245: 463-468.
27. Sacre K, Dehoux M, Chauveheid MP, et al. Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study. J Clin Endocrinol Metab. 2013;98:3199-3205.
28. Terzolo M, Pia A, Reimondo G. Subclinical Cushing's syndrome: definition and management. Clin Endocrinol (Oxf). 2012;76:12-18.
29. Maehana T, Tanaka T, Itoh N, Masumori N, Tsukamoto T. Clinical outcomes of surgical treatment and longitudinal non-surgical observation of patients with subclinical Cushing's syndrome and nonfunctioning adrenocortical adenoma. Indian J Urol. 2012;28: 179-183.
30. Doherty GM, Nieman LK, Cutler GB Jr, Chrousos GP, Norton JA. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome. Surgery 1990;108:1085-1090.
31. Graber AL, Ney RL, Nicholson WE, Island DP, LiddleGW.Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab. 1965;25:11-16.
32. Klose M, Jørgensen K, Kristensen LØ. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas. Clin Endocrinol (Oxf). 2004;61: 394-399.
33. Gordon D, Semple CG, Beastall GH, Thomson JA. A study of hypothalamic- pituitary-adrenal suppression following curative surgery for Cushing's syndrome due to adrenal adenoma. Acta Endocrinol (Copenh). 1987;114:166-170.
34. Muglia LJ, Jacobson L, Weninger SC, et al. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J Clin Invest. 1997;99:2923-2929.
35. Imai T, Sarkar D, Shibata A, et al. Expression of adrenocorticotropin receptor gene in adrenocortical adenomas from patients with Cushing syndrome: possible contribution for the autonomous production of cortisol. Ann Surg. 2001;234:85-91.
36. Morioka M, Fujii T, Matsuki T, et al. Preclinical Cushing's syndrome: report of seven cases and a review of the literature. Int J Urol. 2000;7:126-132.
37. Kleiber H, Rey F, Temler E, Gomez F. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome. J Endocrinol Invest. 1991;14:489-492.
38. Bernini G, Moretti A, Iacconi P, et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol. 2003;148:213-219.
39. MishraAK, Agarwal A, Gupta S, Agarwal G, VermaAK, Mishra SK. Outcome of adrenalectomy for Cushing's syndrome: experience from a tertiary care center. World J Surg. 2007;31:1425-1432.
40. Ambrosi B, Peverelli S, Passini E, et al. Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. Eur J Endocrinol. 1995;132:422-428.
41. Välimäki M, Pelkonen R, Porkka L, Sivula A, Kahri A. Long-term results of adrenal surgery in patients with Cushing's syndrome due to adrenocortical adenoma. Clin Endocrinol (Oxf). 1984;20:229-236.
42. Perry RR, Nieman LK, Cutler GB Jr. Primary adrenal causes of Cushing's syndrome. Diagnosis and surgical management. Ann Surg. 1989;210:59-68.
43. Ross EJ, Linch DC. The clinical response to treatment in adult Cushing's syndrome following remission of hypercortisolaemia. Postgrad Med J. 1985;61:205-211.
44. ScottHWJr, Abumrad NN, Orth DN. Tumors of the adrenal cortex and Cushing's syndrome. Ann Surg. 1985;201:586-594.